From memory the shares issued to Mithra were in the 50's cent mark?
If Mayne did a share buy back with some proceeds at less than this then the cancellation of shares on the register is very cost effective.
What price was the CR done for Teva deal? Again possibly well north of current price therefore share buyback to cancel the dilution from these raises at current price are a good option.
Ann: Annual Report to shareholders, page-8
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.60 |
Change
0.030(0.66%) |
Mkt cap ! $391.3M | |||
| Open | High | Low | Value | Volume |
| $4.59 | $4.62 | $4.51 | $457.1K | 99.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 131 | $4.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.60 | 3549 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MYX (ASX) Chart |